Document is current
Any future updates will be listed below
-
Authors
Salim, Hamza Adel
Yedavalli, Vivek
Lakhani, Dhairya
Milhem, Fathi
Musmar, Basel
Adeeb, Nimer
Simonato, Davide
Li, Yan-Lin
Hajjeh, Orabi
Essibayi, Muhammed Amir
Henninger, Nils
Sundararajan, Sri Hari
Kühn, Anna Luisa
Khalife, Jane
Ghozy, Sherief
Scarcia, Luca
Yeo, Leonard LL.
Tan, Benjamin YQ
Regenhardt, Robert W.
Heit, Jeremy J.
Rouchaud, Aymeric
Fiehler, Jens
Sheth, Sunil
Puri, Ajit S.
Dyzmann, Christian
Colasurdo, Marco
Renieri, Leonardo
Filipe, João Pedro
Harker, Pablo
Radu, Răzvan Alexandru
Abdalkader, Mohamad
Klein, Piers
Ota, Takahiro
Mowla, Ashkan
Naamani, Kareem El
Jabbour, Pascal
Biswas, Arundhati
Clarençon, Frédéric
Siegler, James E.
Nguyen, Thanh N.
Varela, Ricardo
Baker, Amanda
Altschul, David
Gonzalez, Nestor R.
Möhlenbruch, Markus A.
Costalat, Vincent
Gory, Benjamin
Stracke, Christian Paul
Hecker, Constantin
Marnat, Gaultier
Shaikh, Hamza
Griessenauer, Christoph J.
Liebeskind, David S.
Pedicelli, Alessandro
Alexandre, Andrea M.
Faizy, Tobias D.
Tancredi, Illario
Kalsoum, Erwah
Lubicz, Boris
Patel, Aman B.
Fuschi, Maurizio
Wintermark, Max
Guenego, Adrien
Dmytriw, Adam A.
- License Information
-
More Information
Article History
Received: 24 November 2025
Accepted: 11 February 2026
First Online: 10 March 2026
Competing interests
: Dr. Regenhardt serves on a DSMB for a trial sponsored by Rapid Medical, serves as site PI for studies sponsored by Penumbra and Microvention, and receives stroke research grant funding from the National Institutes of Health, Society of Vascular and Interventional Neurology, and Heitman Stroke Foundation. Dr. Guenego reports consultancy for Rapid Medical and Phenox. Dr. Clarençon reports conflicts of interest with Medtronic, Balt Extrusion (consultant), ClinSearch (core lab), Penumbra, Stryker (payment for reading) and Artedrone (Board). Dr. Henninger served as consultant to Omniox and Hydrospire and received support from CDMRP/DoD W81XWH-19-PRARP-RPA, NINDS NS131756, NINR NR020231, and NINDS NS113844. Dr. Liebeskind is consultant as Imaging Core Lab to Cerenovus, Genentech, Medtronic, Stryker, Rapid Medical. Dr. Yeo reports Advisory work for AstraZeneca, is a medical advisor for See-mode, Cortiro and Sunbird Bio, with equity in Ceroflo, and receives substantial support from NMRC Singapore. Dr. Griessenauer reports a proctoring agreement with Medtronic and research funding by Penumbra. Dr. Marnat reports conflicts of interest with Microvention Europe, Stryker Neurovascular, Balt (consulting), Medtronic, Johnson & Johnson and Phenox (paid lectures). Dr. Tjoumakaris is a consultant for Medtronic and Microvention (funds paid to institution). Dr. Jabbour is a consultant for Medtronic, Microvention and Cerus. Dr. Pulli reports consultancy for Microvention, Stryker, Q‘apel, and Nuvascular. Dr. Siegler has served as a consultant for AstraZeneca, and has received funding from the National Institutes of Health (R61NS135583), Viz.ai, Philips, and Medtronic. All other authors declare that there is no conflict of interest.
